Randomised Controlled Clinical Trial To Evaluate The Efficacy Of Kadali Pratisarneeya Kshara In The Management Of Arsha (Second Degree Internal Haemorrhoids)
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 92
- 试验地点
- 1
- 主要终点
- Raktastrav Constipation Size of Arshankur reduces on 1st 7th 14th day
研究概览
简要总结
World wide Prevalance rate of Haemorrhois is 4.4 percentile
Arsha is a common anorectal condition which is on the rise due to factor such as an unhealthy diet and a sedentory lifestyle
The treatment of Arsha through Pratisarneeya Kshar offers several advantages it poses minimal risk of recurrent is cost effective causes less pain and bleeding avoids including inflammation and requires only a short hospital stay for care
Additionally the drug required for this treatmet is readily available and preparation and application of pratisarneeya kshar are strait forward and uncomplicated
The study will be condected on 92 diagnosed patients with 2 degree internal haemorrhoids
Written consent initial assessment
The patient will be divided inti 2 groups
Trial Group A Kadali Pratisarneeya Kshar
Control Group B Apamarga Pratisarneeya Kshar
observation and result will be noted
Discussion and Conclusion
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Open Label
入排标准
- 年龄范围
- 16.00 Year(s) 至 70.00 Year(s)（—）
入选标准
- •Diagnosed patients of Arsha Second degree internal haemorrhoid will be taken foe the study Patients of age between 16yrs to 70yrs will be taken Selection of patient will be done irrespective to Religion Gender and Socioeconomic class.
排除标准
- •Known case of 1st 3rd 4th degree Haemorrhoids Patients having HB less than 8gm percentile Known case of internal Haemorrhoids associated with other anorectal disorder such as fissure in ano fistula in ano Patients with bleeding disorders Patients of Known case of DM HTN Ca rectum Tuberculosis Prolapse of Rectum etc.
结局指标
主要结局
Raktastrav Constipation Size of Arshankur reduces on 1st 7th 14th day
时间窗: Raktastrav Constipation Size of Arshankur reduces on 1st 7th 14th day
次要结局
未报告次要终点